UpToDate Contents

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

1. 良性乳房疾患の概要overview of benign breast disease [show details]
… discussed elsewhere. Atypical hyperplasia (AH) includes both atypical ductal hyperplasia (ADH) and atypical lobular hyperplasia (ALH). AH is a pathologic diagnosis, usually found as an incidental finding …
2. 異型乳管過形成・異型小葉過形成・非浸潤性小葉癌：乳癌のハイリスク病変atypia and lobular carcinoma in situ high risk lesions of the breast [show details]
…proliferative with atypia. Proliferative lesions with atypia include atypical ductal hyperplasia (ADH), atypical lobular hyperplasia (ALH), and lobular carcinoma in situ (LCIS). These lesions are considered …
3. 非浸潤性乳管癌：疫学、臨床症状、および診断breast ductal carcinoma in situ epidemiology clinical manifestations and diagnosis [show details]
…a core biopsy, approximately 10 to 25 percent of lesions histologically interpreted as atypical ductal hyperplasia (ADH) are upgraded to DCIS or invasive cancer at the time of a surgical excision, while …
4. 乳癌予防のための選択的エストロゲン受容体調節因子およびアロマターゼ阻害剤selective estrogen receptor modulators and aromatase inhibitors for breast cancer prevention [show details]
…20 mg orally daily, although lower-dose strategies have been explored in patients with atypical ductal hyperplasia, lobular carcinoma, and ductal carcinoma in situ. These data are discussed in detail elsewhere…
5. 病理学的乳頭分泌の外科的マネージメントsurgical management of pathologic nipple discharge [show details]
…High-risk noncancerous lesions – Biopsy findings of intraductal papillomas, atypical ductal hyperplasia, atypical lobular hyperplasia, and radial scar indicate benign but high-risk lesions. For these patients …